Skip to content

Calculating of Correlations Between ADR, PDR, MAP

Calculating of Correlations Between ADR, PDR, MAP

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03723720
Enrollment
6925
Registered
2018-10-29
Start date
2013-01-31
Completion date
2017-12-31
Last updated
2023-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Neoplasm

Brief summary

The aim of our study is to compare MAP (mean adenoma per colonoscopy) with ADR (adenoma detection rate) and PDR (polyp detection rate) of all colonoscopists in our department

Detailed description

ADR (adenoma detection rate) is generally accepted quality indicator. For possible gaming with ADR other indicators are needed. MAP (mean adenoma per colonoscopy) reflects the quality of examination of entire colon and is considered to be the most objective quality indicator. The aim of our study is to compare MAP with ADR and PDR (polyp detection rate) of all colonoscopists in our department. We want to retrospectively assess the quality indicators of all colonoscopies from January 2013 to December 2017. We want to calculate ADR, PDR and MAP of all our endoscopists for all colonoscopies in patients over 50 years of age excluding therapeutic, IBD, management of complications and sigmoidoscopies (screening, surveillance, diagnostic) and separately only for screening colonoscopies. Correlations between MAP/ADR and MAP/PDR will be performed using Pearson´s correlation coefficient.

Interventions

DEVICEColonoscopy

Endoscopic examination of large bowel

Sponsors

Hospital Frydek-Mistek
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* people over 50 years of age coming for colonoscopic examination (screening, surveillance, diagnostic)

Exclusion criteria

* age under 50 years * indication for colonoscopy: therapeutic, IBD, management of complications and sigmoidoscopies

Design outcomes

Primary

MeasureTime frameDescription
correlation between MAP and ADR for all and screening colonoscopiesjanuary 2013 - december 2017Pearson´s correlation coefficient
correlation between MAP and PDR for all and screening colonoscopiesjanuary 2013 - december 2017Pearson´s correlation coefficient
correlation between ADR and PDR for all and screening colonoscopiesjanuary 2013 - december 2017Pearson´s correlation coefficient

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026